Big Move For Aileron Therapeutics, Inc.
Wed, Sep 14, 2022 at 07:33 PM
Aileron Therapeutics, Inc. (ALRN:NASDAQ) soared at $0.27, a gain of 42.2%. On Wed, Sep 14, 2022, ALRN:NASDAQ touched a New 2-Week High of $0.27. The stock got featured on our News Catalysts scanner on Tue, Sep 06, 2022 at 07:17 AM in the 'MISCELLANEOUS' category. From Wed, Aug 31, 2022, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Wed, Apr 06, 2022 at $0.75 with a volume of 1M+.
About Aileron Therapeutics, Inc. (ALRN:NASDAQ)
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides.
Top 10 Gainers:
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 311.78%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 53.2%
- AMTD International Inc. American Depositary Shares each representing one Class A (AMTD:NYSE), 50%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 42.21%
- Dawson Geophysical Company (DWSN:NASDAQ), 40.18%
- Akerna Corp. (KERN:NASDAQ), 26.92%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 24.4%
- SciSparc Ltd. (SPRC:NASDAQ), 23.89%
- ZeroFox Holdings Inc. (ZFOX:NASDAQ), 22.9%
- Magic Empire Global Limited (MEGL:NASDAQ), 21.51%